Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The poliovirus type 3 capsid protein antigen (Saukett strain) is a structural protein complex derived from the Saukett strain of poliovirus serotype 3. This antigen, composed of VP1, VP2, VP3, and VP4, is a key component in the formulation of inactivated polio vaccines, where it serves as the immunogenic target to elicit protective antibody responses against poliovirus type 3. Recombinant forms are also used for research.
Target of neutralizing antibodies; antigen used to elicit immune responses in vaccines.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Type 3 Capsid Protein (Saukett Strain) (PV3 Capsid (Saukett)).